Beijing drafts first clinical pathway of novel coronavirus cases

Beijing drafted China's first clinical pathway of the novel coronavirus cases in the capital to improve the recovery rate for the disease, in accordance with hospitalization process, medical diagnosis and nursing care for infected patients, according to a Wednesday media briefing in Beijing on battling the virus.

The first edition of the clinical pathway of novel coronavirus cases in Beijing include show suspected cases and those confirmed would be treated at hospitals, and differentiating individual treatment plans for the infected based on their severity.

Issuing the capital's novel coronavirus clinical pathway is aimed at helping more clinical doctors to provide convenience in tracking a patient's disease in diagnosis and standardizing the diagnostic process.

The clinical pathway of Beijing's novel coronavirus cases had already been made public Tuesday on the official websites of Beijing Medical Association and Beijing Medical Doctor Association.